 Hypoglycemic Agents
"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances which lower blood glucose levels.
| Descriptor ID |
D007004
|
| MeSH Number(s) |
D27.505.696.422
|
| Concept/Terms |
Hypoglycemic Agents- Hypoglycemic Agents
- Agents, Hypoglycemic
- Antihyperglycemics
- Antihyperglycemic Agents
- Agents, Antihyperglycemic
- Hypoglycemic Drugs
- Drugs, Hypoglycemic
- Hypoglycemics
Hypoglycemic Effect- Hypoglycemic Effect
- Effect, Hypoglycemic
- Hypoglycemic Effects
- Effects, Hypoglycemic
Antidiabetics- Antidiabetics
- Antidiabetic Drugs
- Drugs, Antidiabetic
- Antidiabetic Agents
- Agents, Antidiabetic
|
Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".
This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 2 | 3 | | 1998 | 0 | 2 | 2 | | 1999 | 3 | 1 | 4 | | 2000 | 1 | 1 | 2 | | 2001 | 1 | 2 | 3 | | 2002 | 1 | 2 | 3 | | 2003 | 6 | 1 | 7 | | 2004 | 5 | 6 | 11 | | 2005 | 3 | 10 | 13 | | 2006 | 3 | 7 | 10 | | 2007 | 11 | 11 | 22 | | 2008 | 11 | 8 | 19 | | 2009 | 15 | 19 | 34 | | 2010 | 16 | 6 | 22 | | 2011 | 14 | 9 | 23 | | 2012 | 22 | 5 | 27 | | 2013 | 18 | 14 | 32 | | 2014 | 28 | 14 | 42 | | 2015 | 22 | 10 | 32 | | 2016 | 22 | 13 | 35 | | 2017 | 31 | 21 | 52 | | 2018 | 36 | 18 | 54 | | 2019 | 30 | 15 | 45 | | 2020 | 22 | 40 | 62 | | 2021 | 10 | 35 | 45 | | 2022 | 6 | 50 | 56 | | 2023 | 6 | 36 | 42 | | 2024 | 42 | 35 | 77 | | 2025 | 65 | 14 | 79 | | 2026 | 27 | 7 | 34 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.
-
DiStefano MJ, Zon J, Olson EG, Levy JF, Anderson GF, Alexander GC. Discontinuation of glucagon-like peptide-1 receptor agonists among US adults: A national survey. J Manag Care Spec Pharm. 2026 Aug; 32(8):903-910.
-
van Baar MJB, Bjornstad P, Touw DJ, Joles JA, Krebber MM, Cherney DZI, van Raalte DH, Muskiet MHA. Renal functional reserve predicts GFR response to empagliflozin in RENALIS and RACELINES clinical trials. Nephrol Dial Transplant. 2026 Jul 31; 41(8):1520-1528.
-
Segev N, Nadeau KJ, Kelsey M, Schaaf LR, Baumgartner A, Riegler A, Wiitala K, Jenkins TM, Xanthakos SA, Helmrath MA, Inge TH, Shah AS. Glycemic Normalization Immediately Following Vertical Sleeve Gastrectomy in Adolescents With Type 2 Diabetes From the ST2OMP Study. Diabetes Obes Metab. 2026 Aug; 28(8):7555-7561.
-
Heerspink HJL, van Raalte DH, Bjornstad P, Bunck MC, Wu P, Tunali I, Milicevic Z, Koeneman L. Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease. Nephrol Dial Transplant. 2026 May 29; 41(6):1058-1068.
-
Sinha R, Uz Zaman S, Mohamed RC, Singh A, Saxena D, Pati AK. Efficacy and Safety of Inhalational Insulin Compared With Rapid-Acting Insulin Analogs: A Systematic Review and Meta-Analysis. Clin Ther. 2026 Aug; 48(8):790-797.
-
Ambalavanan J, Bhasin K, Shah VN. Clinical Guidance on the Safe Use of Sodium-Glucose Cotransporter Inhibitors in Adults with Type 1 Diabetes. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):537-546.
-
Saeed ZI, Shah VN. Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):525-536.
-
Akturk HK. Future of Continuous Ketone Monitoring and Its Utility for Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):515-524.
-
Grammer EE, Stahl ME, Ortiz de Zevallos J, Paterson C, Weltman A, Allen JD. Influence of metformin on exercise metabolism and capacity: a systematic review and meta-analysis. Am J Physiol Endocrinol Metab. 2026 Jun 01; 330(6):E842-E859.
-
Stein A, Pauley M, Snell-Bergeon J. Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):437-453.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|